Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance

W Wu, JL Klockow, M Zhang, F Lafortune… - Pharmacological …, 2021 - Elsevier
Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant,
primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …

Emerging strategies for treating metastasis

M Esposito, S Ganesan, Y Kang - Nature cancer, 2021 - nature.com
The systemic spread of tumor cells is the ultimate cause of the majority of deaths from
cancer, yet few successful therapeutic strategies have emerged to specifically target …

Lipid peroxidation in brain tumors

M Jaganjac, M Cindrić, A Jakovčević, K Žarković… - Neurochemistry …, 2021 - Elsevier
There is a lot of evidence showing that lipid peroxidation plays very important role in
development of various diseases, including neurodegenerative diseases and brain tumors …

A potential mechanism of temozolomide resistance in glioma–ferroptosis

Z Hu, Y Mi, H Qian, N Guo, A Yan, Y Zhang… - Frontiers in …, 2020 - frontiersin.org
Temozolomide (TMZ) is the first-line chemotherapy drug that has been used to treat glioma
for over a decade, but the benefits are limited by half of the treated patients who acquired …

CRISPR/Cas9-mediated gene therapy for glioblastoma: a sco** review

E Begagić, H Bečulić, N Đuzić, A Džidić-Krivić… - Biomedicines, 2024 - mdpi.com
This sco** review examines the use of CRISPR/Cas9 gene editing in glioblastoma (GBM),
a predominant and aggressive brain tumor. Categorizing gene targets into distinct groups …

Ferroptosis-driven nanotherapeutics to reverse drug resistance in tumor microenvironment

L Zhu, D Meng, X Wang, X Chen - ACS Applied Bio Materials, 2022 - ACS Publications
Ferroptosis, characterized by iron-dependent lipid reactive oxygen species (ROS)
accumulation, is non-apoptotic programmed cell death highly relevant to tumor …

Glioblastoma stem cells—useful tools in the battle against cancer

SMB Rodriguez, GA Staicu, AS Sevastre… - International Journal of …, 2022 - mdpi.com
Glioblastoma stem cells (GSCs) are cells with a self-renewal ability and capacity to initiate
tumors upon serial transplantation that have been linked to tumor cell heterogeneity. Most …

The reactive species interactome in the brain

E Malard, S Valable, M Bernaudin, E Pérès… - Antioxidants & Redox …, 2021 - liebertpub.com
Significance: Redox pioneer Helmut Sies attempted to explain reactive species' challenges
faced by organelles, cells, tissues, and organs via three complementary definitions:(i) …

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges

S Zhuo, G He, T Chen, X Li, Y Liang, W Wu… - Frontiers in Molecular …, 2022 - frontiersin.org
Glioblastoma (GBM) is the most common malignant craniocerebral tumor. The treatment of
this cancer is difficult due to its high heterogeneity and immunosuppressive …

The therapeutic potential of aprepitant in glioblastoma cancer cells through redox modification

S Rezaei, R Assaran Darban, H Javid… - BioMed Research …, 2022 - Wiley Online Library
Although there is no doubt regarding the involvement of oxidative stress in the development
of glioblastoma, many questions remained unanswered about signaling cascades that …